Agios Pharmaceuticals, Inc. (0HB0.L)

USD 41.74

(-0.05%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 937.11 Million 1.23 Billion 1.43 Billion 852.95 Million 890.74 Million 858.45 Million
Total Current Assets 833.83 Million 832.77 Million 1.06 Billion 636.67 Million 611.7 Million 613.78 Million
Cash And Short Term Investments 776.92 Million 783.11 Million 1.02 Billion 572.92 Million 564.87 Million 585.3 Million
Cash and Cash Equivalents 88.2 Million 139.25 Million 203.12 Million 127.43 Million 80.93 Million 70.5 Million
Short Term Investments 688.72 Million 643.86 Million 816.89 Million 445.49 Million 483.94 Million 514.79 Million
Net Receivables 2.81 Million 2.2 Million 4.37 Million - 15.31 Million 10.44 Million
Inventory 19.07 Million 8.49 Million - - 7.33 Million 869 Thousand
Other Current Assets 35.02 Million 38.95 Million 39.83 Million 63.74 Million 24.17 Million 17.16 Million
Total Non-Current Assets 103.28 Million 405.94 Million 373.5 Million 216.27 Million 279.03 Million 244.67 Million
Net PPE 69.79 Million 88.11 Million 104.23 Million 116.06 Million 126.1 Million 24.32 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 29.43 Million 313.87 Million 266.37 Million 97.6 Million 152.92 Million 220.11 Million
Tax Assets - - - - - -
Other Non Current Assets 4.05 Million 3.95 Million 2.9 Million 2.6 Million -279.03 Million 238 Thousand
Other Assets - - - 1.00 - -
Total Liabilities 126.09 Million 137.9 Million 145.76 Million 453.45 Million 250.21 Million 170.92 Million
Total Current Liabilities 67.95 Million 62.62 Million 59.82 Million 94.39 Million 92.88 Million 93.5 Million
Account Payables 9.78 Million 18.61 Million 16.7 Million 17.72 Million 21.89 Million 17.88 Million
Tax Payables - - - - - -
Short Term Debt 15 Million 13.66 Million 11.15 Million 7.41 Million 6.91 Million -
Deferred Revenue -15 Million - - - 10.93 Million 32.71 Million
Other Current Liabilities 58.17 Million 30.35 Million 31.96 Million 69.26 Million 53.14 Million 42.91 Million
Total Non Current Liabilities 58.14 Million 75.27 Million 85.93 Million 359.05 Million 157.32 Million 77.41 Million
Long-Term Debt 56.98 Million 71.99 Million 85.93 Million 97.78 Million 106.74 Million -
Deferred Revenue Non Current - - - - 50.58 Million 59.8 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.15 Million 3.27 Million - 261.26 Million 50.58 Million 17.6 Million
Other Liabilities - - - - - 1.00
Total Equity 811.01 Million 1.1 Billion 1.29 Billion 399.5 Million 640.52 Million 687.53 Million
Stock Holders Equity 811.01 Million 1.1 Billion 1.29 Billion 399.5 Million 640.52 Million 687.53 Million
Common Stock 72 Thousand 71 Thousand 71 Thousand 69 Thousand 68 Thousand 58 Thousand
Retained Earnings -822.64 Million -470.56 Million -238.76 Million -1.84 Billion -1.51 Billion -1.1 Billion
Accumulated other comprehensive income -441 Thousand -12.53 Million -1.19 Million 105 Thousand 202 Thousand -2.17 Million
Common Stock Equity 811.01 Million 1.1 Billion 1.29 Billion 399.5 Million 640.52 Million 687.53 Million
Capital Lease Obligation 71.99 Million 71.99 Million 85.93 Million 97.78 Million 106.74 Million -
Total Investments 718.15 Million 957.73 Million 1.08 Billion 543.1 Million 636.87 Million 734.91 Million
Total Debt 56.98 Million 85.65 Million 97.09 Million 105.19 Million 113.66 Million -
Net Debt -31.21 Million -53.6 Million -106.03 Million -22.23 Million 32.73 Million -70.5 Million

Balance Sheet Charts